Brief: Moberg Pharma Resolves Directed Issue Of Units To Guarantors In Connection With Completed Rights Issue

Moberg Pharma AB (publ)

08/09/2023 10:34

Sept 8 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * MOBERG PHARMA RESOLVES A DIRECTED ISSUE OF UNITS TO
GUARANTORS
IN CONNECTION WITH COMPLETED RIGHTS ISSUE
    * AS COMMUNICATED IN CONNECTION WITH RIGHTS ISSUE,
GUARANTORS, IN
ACCORDANCE WITH ISSUE GUARANTEE AGREEMENTS ENTERED INTO, HAD
OPTION OF RECEIVING THEIR GUARANTEE COMMISSION IN FORM OF CASH
CORRESPONDING TO TWELVE (12) PERCENT OF AMOUNT GUARANTEED OR IN
FORM OF NEWLY ISSUED UNITS CORRESPONDING TO FOURTEEN (14)
PERCENT OF AMOUNT GUARANTEED
    * DUE TO THIS, MOBERG PHARMA'S BOARD OF DIRECTORS HAS TODAY
RESOLVED ON A DIRECTED NEW ISSUE OF A TOTAL OF 664,370 UNITS TO
THESE GUARANTORS. EACH UNIT CONSISTS OF ONE (1) ORDINARY SHARE
AND ONE (1) WARRANT OF SERIES 2023:1
    * EACH WARRANT OF SERIES 2023:1 ENTITLES HOLDER TO SUBSCRIBE
FOR
ONE (1) NEW ORDINARY SHARE IN COMPANY DURING PERIOD 5 JUNE 2024
UP TO AND INCLUDING 19 JUNE 2024
    * SUBSCRIPTION PRICE FOR SUBSCRIPTION OF ORDINARY SHARES
WITH
SUPPORT OF WARRANTS OF SERIES 2023:1 WILL CORRESPOND TO 70
PERCENT OF VOLUME-WEIGHTED AVERAGE PRICE IN COMPANY'S ORDINARY
SHARE DURING PERIOD FROM AND INCLUDING 20 MAY 2024 UP TO AND
INCLUDING 31 MAY 2024
    * HOWEVER, SUBSCRIPTION PRICE CAN AT MINIMUM AMOUNT TO QUOTA
VALUE
OF SHARE, CORRESPONDING TO APPROXIMATELY SEK 1.0 PER ORDINARY
SHARE

Source text for Eikon:  ID:nWkr5KFB8V 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))